Getein Biotech Inc Total Liabilities

Latest as of March 2026: CN¥765.68 Million CNY ≈ $112.04 Million USD

Getein Biotech Inc total liabilities. Based on the latest financial reports, Getein Biotech Inc (603387) has total liabilities worth CN¥765.68 Million CNY (≈ $112.04 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Getein Biotech Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Getein Biotech Inc (2012–2025)

Total liabilities of Getein Biotech Inc from 2012 to 2025. This chart illustrates how Getein Biotech Inc's total liabilities have evolved over time, based on quarterly financial data.

Getein Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Getein Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Innova Captab Limited NSE:INNOVACAP	India	Rs-10.91 Billion
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D IS:KRDMD	Turkey	TL35.63 Billion
ECN Capital Corp TO:ECN	Canada	CA$757.90 Million
Mama's Creations Inc. NASDAQ:MAMA	USA	$34.02 Million
Stingray Group Inc TO:RAY-A	Canada	CA$866.47 Million
Costar Group Co Ltd SHE:002189	China	CN¥1.96 Billion
DBAPPSecurity Co Ltd SHG:688023	China	CN¥1.85 Billion
Wereldhav B-Sicafi BR:WEHB	Belgium	€460.95 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Getein Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Getein Biotech Inc balance sheet assets.

Liquidity & Leverage Metrics

Getein Biotech Inc Total Liabilities Ratios Explained

Getein Biotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Getein Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Getein Biotech Inc (2012–2025)

The table below shows the annual total liabilities of Getein Biotech Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥896.55 Million ≈ $131.19 Million	-9.11%
2024-12-31	CN¥986.42 Million ≈ $144.34 Million	-4.27%
2023-12-31	CN¥1.03 Billion ≈ $150.78 Million	+1.73%
2022-12-31	CN¥1.01 Billion ≈ $148.21 Million	+17.24%
2021-12-31	CN¥863.90 Million ≈ $126.42 Million	+24.13%
2020-12-31	CN¥695.95 Million ≈ $101.84 Million	+113.49%
2019-12-31	CN¥325.98 Million ≈ $47.70 Million	+74.11%
2018-12-31	CN¥187.23 Million ≈ $27.40 Million	+57.50%
2017-12-31	CN¥118.87 Million ≈ $17.39 Million	+30.45%
2016-12-31	CN¥91.13 Million ≈ $13.33 Million	+53.21%
2015-12-31	CN¥59.48 Million ≈ $8.70 Million	+44.16%
2014-12-31	CN¥41.26 Million ≈ $6.04 Million	-41.41%
2013-12-31	CN¥70.42 Million ≈ $10.31 Million	+43.27%
2012-12-31	CN¥49.15 Million ≈ $7.19 Million	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$631.55 Million

CN¥4.32 Billion CNY

Market Cap Rank

#10741 Global

#2898 in China

Share Price

CN¥8.51

Change (1 day)

-2.41%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49